HCONRES 42 United States House · 117th Congress

Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines.

Summary

This concurrent resolution expresses the sense of Congress that government entities should consider using a portion of proceeds from litigation against opioid manufacturers and distributors for drug take-back programs.

Issues: ✓ Healthcare

Bill status in committee 1 of 4 stages cleared

Introduction

Jul 2021

Committee Review

Floor Vote

President

Introduced Jul 21, 2021 Last action Jul 22, 2021

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Jul 22, 2021

Committee

Referred to the Subcommittee on Health.

lower

Jul 21, 2021

Committee

Referred to the House Committee on Energy and Commerce.

lower

Jul 21, 2021

Introduced

Introduced in House

lower

1 primary · 17 co-sponsors

Sponsors

Role

Legislator

Party

State

District